Advancing Cancer Immunotherapy Through Next-Generation Lipid Nanoparticles with Reduced PEG Immunogenicity and Enhanced Spleen- Targeted Delivery (2027-2031)
Experts
Dr
Changkui Fu
UQ Amplify Senior Fellow
Australian Institute for Bioengineering and Nanotechnology
